Nanofiber Solutions
Carly Schwartz has a diverse work experience spanning multiple companies and roles. In 2019, they worked as a Student Assistant at The Ohio State University Wexner Medical Center and as a Student Volunteer at Temple University - Lewis Katz School of Medicine. In these positions, they gained valuable experience in various lab techniques and assays related to cellular analysis and signaling pathways.
In 2020, Carly joined DePuy Synthes Companies as a Clean and Pack Manufacturing Process Engineering Co-Op. Carly successfully led projects to improve manufacturing processes and conducted testing to validate proposed solutions. Carly also gained knowledge in areas such as non-conformance records, validations, and 6 Sigma activities.
Carly's most recent work experience began in 2020 at Nanofiber Solutions, where they started as a Research and Development Intern. Carly worked on various projects and contributed to the development of new technologies. In 2022, they transitioned to the role of Project Engineer at the same company.
Overall, Carly's work experience demonstrates their versatility in both laboratory and engineering settings, as well as their ability to successfully contribute to projects and improve processes.
Carly Schwartz completed their Bachelor of Science (BS) degree in Biomedical/Medical Engineering at The Ohio State University. Carly attended the university from 2017 to 2022.
This person is not in any teams
This person is not in any offices
Nanofiber Solutions
1 followers
Nanofiber Solutions develops and markets electrospun nanofiber substrates for cell culture and drug development applications in standard multiwell plates or it can be scaled for larger configurations. Historically, general cell culture has been performed on flat, tissue culture polystyrene (TCPS) because it is cheap, optically clear, and many cellsgrow well on it. In reality, however, living organisms are made up of an extracellular matrix (ECM) that presents both aligned physical structure and mechanical support to the cells. Adherent cells are complex, self-sustaining units that require ECM anchorage to proliferate and undergo normal differential function. TCPS lacks this aligned three-dimensional (3-D) component and cells behave very differently on this flat, smooth substrate than they do in true biological settings. Not surprisingly, drugs developed using TCPS as an in vitro substrate experience a >99% failure rate in clinical studies.